On July 16, 2026, JPMorgan Chase Financial Company LLC issued $368 million worth of structured notes maturing on July 21, 2031, offering leveraged exposure to the iShares MSCI EAFE ETF and EURO STOXX 50 Index. Fully guaranteed by JPMorgan Chase & Co., these notes provide a 2.25x upside leverage on the lesser-performing underlying asset. Investors should be aware of the risk of principal loss if either underlying falls below its barrier level, and that no interest or dividend payments will be made during the term.
Key Points
- NYSE: VYLD 026 structured notes from JPMorgan Chase Financial offering 2.25x leveraged uncapped upside on the weaker-performing international equity underlying
- $368 million principal issued, priced July 16, 2026, with settlement expected July 21, 2026, and maturity on July 21, 2031
- Initial pricing values: iShares MSCI EAFE ETF at $103.81 and EURO STOXX 50 Index at 6,283.61; barrier set at 65% of initial value for each underlying
- Investors receive principal plus leveraged gains if both underlyings appreciate; principal only if either declines but stays above barrier; losses exceeding 35% of principal if barrier breached
Overview of the Uncapped Accelerated Barrier Notes Structure
JPMorgan Chase Financial Company LLC issued $368 million in Uncapped Accelerated Barrier Notes with a minimum denomination of $1,000. These unsecured and unsubordinated obligations are fully and unconditionally guaranteed by JPMorgan Chase & Co. Notably, the notes are linked individually to the performance of two separate underlyings—the iShares MSCI EAFE ETF (Bloomberg: EFA) and the EURO STOXX 50 Index (Bloomberg: SX5E)—rather than a combined basket, which affects payout and risk profiles.
The notes track the lesser-performing asset between the two underlyings, offering a 2.25x leverage factor on appreciation above initial values. This uncapped upside design allows unlimited potential returns if the weaker-performing underlying rises significantly.
Initial Pricing and Barrier Levels
At pricing on July 16, 2026, the iShares MSCI EAFE ETF closed at $103.81, and the EURO STOXX 50 Index closed at 6,283.61. The barrier for each underlying is set at 65% of these initial values—$67.4765 for the ETF and 4,084.3465 for the index—defining the threshold for principal loss risk.
The iShares MSCI EAFE ETF’s share adjustment factor is fixed at 1.0 at pricing but may adjust due to corporate actions, introducing complexity that investors must monitor during the five-year term.
Upside Payment Structure and Return Potential
If both underlyings close above their initial values on the observation date of July 16, 2031, investors receive $1,000 plus 2.25 times the return of the lesser-performing asset. For example, a 50% gain in the weaker underlying results in a $2,125 payout per $1,000 principal. An 80% gain would yield $2,800 per $1,000 principal, illustrating the uncapped leveraged upside.
This structure targets investors anticipating broad international equity appreciation who seek amplified returns while foregoing interest and dividends.
Principal Protection Under Moderate Declines
If either underlying’s final value is below its initial value but remains above the 65% barrier, investors receive full principal at maturity. For instance, a 20% decline above the barrier results in principal repayment with no gain or loss, but no income is paid during the term.
This breakeven scenario requires investors to accept the opportunity cost of no interest or dividends over five years, with the barrier allowing up to a 35% decline without principal loss.
Downside Risk and Principal Loss Scenarios
Should either underlying fall below its barrier (a decline exceeding 35%), investors face losses proportional to the lesser-performing asset’s decline without leverage protection. For example, a 40% drop results in a $600 payout per $1,000 principal, and a 100% drop leads to total principal loss.
This asymmetric risk-return profile—leveraged upside but unleveraged downside—is critical for investors to understand.
Credit Risk and Guarantee Details
Payments depend on the creditworthiness of JPMorgan Chase Financial Company LLC as issuer and JPMorgan Chase & Co. as guarantor. The notes are not bank deposits, lack FDIC or governmental insurance, and are unsecured corporate obligations, exposing investors to credit risk of the JPMorgan Chase group.
Pricing, Fees, and Estimated Value
The notes priced at $1,000 each, totaling $368 million. Fees and commissions of $6 per note reduced net proceeds to $994 per note, or approximately $365.8 million. J.P. Morgan Securities LLC will distribute commissions to affiliated and unaffiliated dealers.
The estimated intrinsic value at pricing was $969.60 per note, reflecting a roughly 3% discount to the public price, indicating distribution markups included in the offering price.
International Equity Exposure and Underlying Asset Selection
The notes provide exposure to developed international equities outside North America via the iShares MSCI EAFE ETF and to Eurozone large-cap stocks through the EURO STOXX 50 Index. Linking to the lesser-performing underlying caps returns at that asset’s performance but applies leverage to gains, appealing to investors bullish on international markets seeking leveraged exposure.
However, both underlyings are heavily European-focused, introducing correlation risk and potential concentrated exposure to European market shocks.
Settlement Schedule and Market Disruption Clauses
The notes were priced on July 16, 2026, with expected settlement around July 21, 2026, and maturity on July 21, 2031. The observation date is July 16, 2031. Both observation and maturity dates may be postponed due to market disruption events, and early acceleration may occur under certain conditions, potentially altering payment timing.
Investor Suitability and Risk Considerations
Investors must accept the absence of interest and dividend income and the risk of losing some or all principal. These notes suit investors seeking uncapped 2.25x leveraged returns on the weaker-performing underlying and who understand the complex leverage and barrier features involved.
Prospective buyers should carefully review all risk disclosures in the prospectus and product supplements before investing.